Table 1.
Patient demographics and intervention details.
Patient variables | |
Age [years] | 61.23 ± 12.4 |
Male | 22 (71) |
Female | 9 (29) |
ASA I | 0 |
ASA II | 0 |
ASA III | 18 (58) |
ASA IV | 13 (41) |
Pre-op ACE inhibitor/ARB | 13 (42) |
Pre- op calcium blocker | 3 (10) |
Pre- op beta blocker | 14 (45) |
Pre- op heparin | 0 |
Pre- op hemoglobin [g/dL] | 13.96 ± 1.53 |
EUROscore variables | |
Chronic pulmonary disease | 4 (13) |
Extracardiac arteriopathy | 31 (100) |
Neurological dysfunction | 0 |
Serum creatinine >200mmol/L | 4 (13) |
Poor mobility | 1 (3) |
Pre-op EF (TEE) >50 | 20 (65) |
Pre- op EF (TEE) 31–50 | 11 (36) |
Pre- op EF (TEE) <30 | 0 |
Recent myocardial infarction | 1 (3) |
Pulmonary hypertension | 3 (10) |
Previous cardiac surgery | 3 (10) |
Diabetic on insulin | 0 |
Logistic EUROscore [%] | 18.9 ± 12 |
Surgical variables | |
Ascending aorta only | 9 (29) |
Ascending aorta +CABG | 2 (6) |
Ascending aorta +valve | 20 (65) |
Antegrade cerebral perfusion | 30 (97) |
Retrograde cerebral perfusion | 1 (3) |
CPB time [min] | 169.5 ± 45.4 |
Crossclamp time [min] | 118.8 ± 35.7 |
Circulatory arrest time [min] | 13 [11; 16] |
NP temp at circulatory arrest [C°] | 22.4 ± 4.0 |
Post- op EF (TEE) >50 | 21 (68) |
Post- op EF (TEE) 31–50 | 10 (32) |
Post- op EF (TEE) <30 | 0 |
FFP transfusion [units] | 4 [0; 4] |
RBC transfusion [units] | 0 [0; 1] |
Platelet transfusion [units] | 2 [1.5; 2] |
Cryoprecipitate transfusion [units] | 0 [0; 1] |
Post-OP hemoglobin [g/dL] | 10.1 ± 0.84 |
Values are expressed as mean ± SD, median [interquartile range], or number (percentage).
ACE: angiotensin converting enzyme; ARB: angiotensin II receptor blocker; ASA: American Society of Anesthesiologists physical status classification system; CABG: coronary artery bypass grafting; CPB: cardiopulmonary bypass; EF: ejection fraction (determined by transesophageal echocardiography [TEE]); EUROscore: European System for Cardiac Operative Risk Evaluation score; FFP: fresh-frozen plasma; NP temp: nasopharyngeal temperature; RBC: red blood cell.